Product logins

Find logins to all Clarivate products below.


: Oncology

Here you will find relevant articles and insight into all Clarivate related products and news.

These six radioligand therapy companies to watch are ushering in a new era of precision oncology These six radioligand therapy companies to watch are ushering in a new era of precision oncology
Blog June 18, 2025
These six radioligand therapy companies to watch are ushering in a new era of precision oncology
Biopharma Clinical research Market Access
The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
Blog June 21, 2024
The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
Clinical research Clinical trials corporate
These seven ADC makers are developing therapies that show promise for hard-to-treat cancers These seven ADC makers are developing therapies that show promise for hard-to-treat cancers
Blog June 17, 2024
These seven ADC makers are developing therapies that show promise for hard-to-treat cancers
Clinical research Early drug development research Oncology
Indication Expansion: Pioneering new uses for existing cancer drugs Indication Expansion: Pioneering new uses for existing cancer drugs
Blog May 31, 2024
Indication Expansion: Pioneering new uses for existing cancer drugs
Clinical research Clinical trials Consulting Resource Center
Pharma is placing bigger bets on fewer, more strategic assets and platforms Pharma is placing bigger bets on fewer, more strategic assets and platforms
Blog May 8, 2024
Pharma is placing bigger bets on fewer, more strategic assets and platforms
Oncology Pharma Portfolio strategy
What sets the Drugs to Watch in 2024 apart What sets the Drugs to Watch in 2024 apart
Blog January 8, 2024
What sets the Drugs to Watch in 2024 apart
Clinical trials Mainland China Oncology
What to watch in the life sciences in 2024 What to watch in the life sciences in 2024
Blog December 14, 2023
What to watch in the life sciences in 2024
Oncology Pharma Portfolio strategy
Five points on CMS's first ten picks for price negotiations Five points on CMS's first ten picks for price negotiations
Blog October 25, 2023
Five points on CMS's first ten picks for price negotiations
Health policy Inflation Reduction Act IRA

Oncology

Blog May 24, 2016
Are Narrow Networks the key to telemedicine growth?
Blog May 17, 2016
Oil and Healthcare: Oil Prices Create Havoc in the Land of Soccer and Samba
Blog May 13, 2016
More exchanges with a lone insurer on tap for 2017
Blog May 13, 2016
Interventional Oncology – here come the big guns
Blog May 12, 2016
Digital health news update: Merger mania; advertising's existential dillema
Blog February 10, 2016
Latin America scrambles to contain Zika virus
Blog October 22, 2015
War on Cancer: A Unified Battle in the 21st Century
Blog October 3, 2015
The Decision Resources Group Companies Are Now DRG
Blog June 3, 2015
Medical devices for the everyday consumer: in more places than you'd think
Blog May 28, 2015
Is there anyone that does not love the PCSK9 inhibitors?